Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$186K Sell
3,413
-71
-2% -$3.46K ﹤0.01% 759
2026
Q1
$149K Buy
3,484
+92
+3% +$3.96K ﹤0.01% 794
2025
Q4
$149K Buy
3,392
+177
+6% +$7.32K ﹤0.01% 777
2025
Q3
$133K Sell
3,215
-99
-3% -$3.98K ﹤0.01% 756
2025
Q2
$146K Buy
3,314
+415
+14% +$16.6K ﹤0.01% 690
2025
Q1
$107K Buy
2,899
+1,538
+113% +$54.8K ﹤0.01% 742
2024
Q4
$45.3K Buy
1,361
+553
+68% +$17.9K ﹤0.01% 956
2024
Q3
$21K Buy
808
+686
+562% +$17.1K ﹤0.01% 1209
2024
Q2
$2.74K Buy
122
+38
+45% +$843 ﹤0.01% 1659
2024
Q1
$1.99K Buy
+84
New +$1.87K ﹤0.01% 1539
2023
Q4
Sell
-1,267
Closed -$27.7K 1650
2023
Q3
$27.7K Hold
1,267
﹤0.01% 984
2023
Q2
$24.2K Hold
1,267
﹤0.01% 1045
2023
Q1
$24.6K Hold
1,267
﹤0.01% 1028
2022
Q4
$20K Sell
1,267
-1,000
-44% -$16.3K ﹤0.01% 1104
2022
Q3
$36K Sell
2,267
-1,646
-42% -$31.8K ﹤0.01% 948
2022
Q2
$81K Buy
3,913
+1,267
+48% +$26.1K ﹤0.01% 792
2022
Q1
$60K Sell
2,646
-181
-6% -$3.54K ﹤0.01% 912
2021
Q4
$52K Buy
+2,827
New +$54.1K ﹤0.01% 983

Other funds holding EXEL

UMB Bank's EXEL Position: Q2 2026 in Review

UMB Bank reduced its Exelixis (EXEL) stake by 2% in Q2 2026, selling an estimated $3.46K and leaving 3,413 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #759.

UMB Bank first reported a position in EXEL in Q4 2021 and has held it in 18 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • UMB Bank held 3,413 shares of Exelixis worth $186K as of Q2 2026.
  • UMB Bank sold 71 Exelixis shares in Q2 2026, an estimated $3.46K.
  • Exelixis made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #759 holding.
  • UMB Bank first reported a position in Exelixis in Q4 2021 and has held it in 18 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.